Vernon Hills, IL, May 25, 2005 - A biomarker pioneered by Applied NeuroSolutions (OTC BB: APNS, www.appliedneurosolutions.com) and exclusively utilized in its Alzheimer's diagnostic assay, shows great ...

VERNON HILLS, Ill.--(BUSINESS WIRE)--Biopharmaceutical company Applied NeuroSolutions, Inc. (OTCBB:APNS)(www.appliedneurosolutions.com) today announced an agreement with Eli Lilly and Company ...

Applied NeuroSolutions, Inc. has announced that Eli Lilly and Company has agreed to a one-year renewal of its drug discovery collaboration. Lilly will pay $250,000 to Applied NeuroSolutions for the ...

Vernon Hills, IL, June 20, 2005 -- A group of researchers led by Applied NeuroSolutions' (OTC BB: APNS; www.appliedneurosolutions.com) founding scientist Dr. Peter Davies, have identified an abnormal ...

Perth-based neurology-focused research and development company NeuroDiscovery Ltd's 100 per cent subsidiary, NeuroSolutions Ltd has formed a new one year collaborative agreement drive the development ...

Applied NeuroSolutions has inked a development deal with Eli Lilly for new drugs to treat Alzheimer's. Applied NeuroSolutions gains $2 million up front along with research funds. And it stands to earn ...

NeuroSolutions current clients include many other established pharmaceutical and biotechnology companies. In parallel to running its service business, the Company is also exploiting its in house ...